ArticlebioRxiv : the preprint server for biology2025
Enhanced fluorescence lifetime imaging microscopy denoising via principal component analysis.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
5 authors.
Funding
Abstract
Fluorescence Lifetime Imaging Microscopy (FLIM) quantifies the autofluorescence lifetime to measure cellular metabolism, therapeutic efficacy, and disease progression. These dynamic processes are intrinsically heterogeneous, increasing the complexity of the signal analysis. Often noise reduction strategies that combine thresholding and non-selective data smoothing filters are applied. These can result in error introduction and data loss. To mitigate these issues, we develop noise-corrected principal component analysis (NC-PCA). This approach isolates the signal of interest by selectively identifying and removing the noise. To validate NC-PCA, a secondary analysis of FLIM images of patient-derived colorectal cancer organoids exposed to a range of therapeutics was performed. First, we demonstrate that NC-PCA decreases the uncertainty up to 4-fold in comparison to conventional analysis with no data loss. Then, using a merged data set, we show that NC-PCA, unlike conventional methods, identifies multiple metabolic states. Thus, NC-PCA provides an enabling tool to advance FLIM analysis across fields.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.